Guan Xu-Min, Li Dan-Na, Zhao Fu-Lu, Zhao Yan-Ni, Yang Yi-Heng, Dai Bai-Ling, Dai Shi-Yu, Gao Lian-Jun, Xia Yun-Long, Dong Ying-Xue
Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Front Cardiovasc Med. 2022 May 6;9:824194. doi: 10.3389/fcvm.2022.824194. eCollection 2022.
This study aimed to explore the outcomes of His-Purkinje conduction system pacing (HPCSP) and to screen the predictors of left ventricular (LV) complete reverse remodeling in patients with true left bundle branch block (LBBB) and heart failure with reduced ejection fraction (HFrEF).
Patients who underwent HPCSP for true LBBB and HFrEF from April 2018 to August 2020 were consecutively enrolled. All participants were followed up for at least 1 year. Thrombosis, infection, lead dislodgement, perforation, and other complications were observed after HPCSP. Clinical data, including echocardiographic parameters, electrocardiogram measurements, and cardiac function, were assessed before and after the procedure.
A total of 46 patients were enrolled. HPCSP was successfully deployed in 42 cases (91.30%), which included 37 cases with His bundle pacing (HBP) and 5 cases with left bundle branch pacing (LBBP). The QRS duration decreased significantly (169.88 ± 19.17 ms vs. 113.67 ± 20.68 ms, < 0.001). Left ventricular end-systolic volume (LVESV) (167.67 ± 73.20 ml vs. 85.97 ± 62.24 ml, < 0.001), left ventricular end-diastolic diameter (LVEDD) (63.57 ± 8.19 mm vs. 55.46 ± 9.63 mm, = 0.003) and left ventricular ejection fraction (LVEF) (26.52 ± 5.60% vs. 41.86 ± 11.56%, < 0.001) improved dramatically. Complete reverse remodeling of the LV with normalized LVEF and LVEDD was found in nearly half of the patients (45.24%). A short QRS duration after HPCSP was a strong predictor of normalized LVEF and LVEDD ( < 0.001). The thresholds increased markedly in two patients approximately 6 months after HBP. No patients died during the total follow-up period of 20.07 ± 6.45 months.
Complete reverse remodeling of the LV could be found in nearly half of the patients with HFrEF and true LBBB after HPCSP, and the short QRS duration after HPCSP was a strong predictor.
本研究旨在探讨希氏-浦肯野传导系统起搏(HPCSP)的效果,并筛选真正左束支传导阻滞(LBBB)和射血分数降低的心力衰竭(HFrEF)患者左心室(LV)完全逆向重构的预测因素。
连续纳入2018年4月至2020年8月因真正LBBB和HFrEF接受HPCSP的患者。所有参与者均随访至少1年。观察HPCSP术后的血栓形成、感染、导线脱位、穿孔及其他并发症。评估手术前后的临床资料,包括超声心动图参数、心电图测量值和心功能。
共纳入46例患者。42例(91.30%)成功进行了HPCSP,其中希氏束起搏(HBP)37例,左束支起搏(LBBP)5例。QRS波时限显著缩短(169.88±19.17 ms对113.67±20.68 ms,<0.001)。左心室收缩末期容积(LVESV)(167.67±73.20 ml对85.97±62.24 ml,<0.001)、左心室舒张末期直径(LVEDD)(63.57±8.19 mm对55.46±9.63 mm,=0.003)和左心室射血分数(LVEF)(26.52±5.60%对41.86±11.56%,<0.001)显著改善。近一半患者(45.24%)出现LV完全逆向重构,LVEF和LVEDD恢复正常。HPCSP术后QRS波时限短是LVEF和LVEDD恢复正常的有力预测因素(<0.001)。两名患者在HBP后约6个月阈值显著升高。在20.07±6.45个月的总随访期内无患者死亡。
HPCSP术后近一半HFrEF和真正LBBB患者可出现LV完全逆向重构,HPCSP术后QRS波时限短是有力的预测因素。